glp 1 drugs and bipolar disorder Glucagon-like Peptide-1 receptor agonists as emerging therapeutics in disorder: a narrative review of preclinical clinical evidence GLP-1 receptor agonists show promise

Please talk with your doctor about the risks and side effects before starting any GLP-1 medication

Shah P, Ardestani A, Dharmadhikari G, Laue S, Schumann DM, Kerr-Conte J, et al

If you are on commercial insurance , contact your insurer or benefits administrator to understand your current GLP-1 coverage, prior authorization rules, and cost-sharing

How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help provide context by revealing predispositions in GLP-1 receptor (rs6923761), GIPR (rs1800437), and metabolic pathways (FTO rs9939609, MC4R rs17782313)

However, GLP-1 RAs may be considered to lower the CV risk in patients with T2D who have a high to very high risk of CVD, (class IIb, level C)

Step 3: Activate your device to start tracking your progress